Talk:Zaleplon: Difference between revisions
>Brack created zaleplon |
>Corticosteroid Grammatics |
||
Line 1: | Line 1: | ||
{{headerpanel|{{proofread}}{{Approval}}}} | {{headerpanel|{{proofread}}{{Approval}}}} | ||
'''Zaleplon''' (trade name '''Sonata''') is a non-benzodiazepine hypnotic drug. | '''Zaleplon''' (trade name '''Sonata''') is a non-benzodiazepine hypnotic drug. It is of the [[psychoactive class::hypnotic]] and [[psychoactive class::depressant]] psychoactive classes and is chemically a [[chemical class::pyrazolopyrimidine]]. | ||
==History and culture== | ==History and culture== | ||
{{historyStub}} | {{historyStub}} | ||
Line 9: | Line 9: | ||
==Pharmacology== | ==Pharmacology== | ||
{{pharmacology}} | {{pharmacology}} | ||
Zaleplon is a GABA A receptor agonist | Zaleplon is a GABA<sub>A</sub> receptor agonist. {{citation needed}} | ||
==Subjective effects== | ==Subjective effects== | ||
{{EffectStub}} | {{EffectStub}} | ||
Line 27: | Line 27: | ||
*[[Amnesia]] | *[[Amnesia]] | ||
*[[Novelty enhancement]] | *[[Novelty enhancement]] | ||
*[[Sleepiness]] & [[Wakefulness]] - Sleepiness is felt during the come up but is often later replaced with [[wakefulness]] during the peak | *[[Sleepiness]] & [[Wakefulness]] - Sleepiness is felt during the come up but is often later replaced with [[wakefulness]] during the peak. | ||
*[[Suicidal ideation]] | *[[Suicidal ideation]] | ||
}} | }} | ||
Line 40: | Line 40: | ||
*[[Unspeakable horrors]] | *[[Unspeakable horrors]] | ||
*[[Autonomous entities]] | *[[Autonomous entities]] | ||
*[[External hallucinations]] - Hallucinations on zaleplon are usually interactive in style | *[[External hallucinations]] - Hallucinations on zaleplon are usually interactive in style and vary in beliveability. | ||
}} | }} | ||
Line 58: | Line 58: | ||
==Toxicity and harm potential== | ==Toxicity and harm potential== | ||
{{toxicity}} | {{toxicity}} | ||
As with other Z-drugs, zaleplon use may result in | As with other Z-drugs, zaleplon use may result in bizarre and dangerous behavior. | ||
It is strongly recommended that one use [[responsible use|harm reduction practices]] when using this substance. | It is strongly recommended that one use [[responsible use|harm reduction practices]] when using this substance. | ||
===Lethal dosage=== | ===Lethal dosage=== | ||
===Tolerance and addiction potential=== | ===Tolerance and addiction potential=== | ||
Zaleplon has a much lower addiction potential than other non-benzodiazepines and often has little to no withdrawal effects. | Zaleplon has a much lower addiction potential than other non-benzodiazepines and often has little to no withdrawal effects.'''{{citation needed}}''' | ||
===Dangerous interactions=== | ===Dangerous interactions=== | ||
{{DangerousInteractions}} | {{DangerousInteractions}} | ||
Line 70: | Line 70: | ||
==Legal status== | ==Legal status== | ||
{{LegalStub}} | {{LegalStub}} | ||
*United | *'''United States''' - Zaleplon is Schedule 4 under the Controlled Substance Act (CSA). Possession without a prescription is illegal. | ||
*Canada - Zaleplon is not scheduled in | *'''Canada''' - Zaleplon is not scheduled in Canada. {{citation needed}} | ||
==See also== | ==See also== | ||
*[[Responsible use]] | *[[Responsible use]] |